15B10626P00000087

ONCO 360: MODEYSO (DORADVIPRONE) MEDICATION DOS: NOVEMBER 12, 2025 THRU SEPTEMBER 30, 2026 ORDERS PLACED AS NECESSARY BY PROVIDER FUNDS WILL BE OBLIGATED THROUGH A MOD UPON THE OFFICIAL ANNOUNCEMENT OF THE CR DATE

Federal Prison System / Bureau of Prisons · United States

This contract has been awarded. Browse open opportunities

View Source

Time Left to Bid

Awarded

AwardedOtherFederal

Basic information

Reference number: 15B10626P00000087
Issuing organization: Federal Prison System / Bureau of Prisons · Find award history →
Government level: Federal
Solicitation type: Other
Title: ONCO 360: MODEYSO (DORADVIPRONE) MEDICATION DOS: NOVEMBER 12, 2025 THRU SEPTEMBER 30, 2026 **ORDERS PLACED AS NECESSARY BY PROVIDER** FUNDS WILL BE OBLIGATED THROUGH A MOD UPON THE OFFICIAL ANNOUNCEMENT OF THE CR DATE
Source: USASpending (Federal)
Source ID: usa-15B10626P00000087

Details

Location: United States

Description

ONCO 360: MODEYSO (DORADVIPRONE) MEDICATION DOS: NOVEMBER 12, 2025 THRU SEPTEMBER 30, 2026 **ORDERS PLACED AS NECESSARY BY PROVIDER** FUNDS WILL BE OBLIGATED THROUGH A MOD UPON THE OFFICIAL ANNOUNCEMENT OF THE CR DATE Awarded to: SINA DRUG LLC Agency: Department of Justice Sub-agency: Federal Prison System / Bureau of Prisons Award type: PURCHASE ORDER

Dates

Publication: 2025/11/12 12:00:00 AM UTC
Closing date: 2026/09/30 12:00:00 AM UTC

Estimated value

$116K USD

Classification

Normalized category

Other

Source: USASpending (Federal)

Last updated 2026-05-25, 2:30:28 p.m.

Data refreshed every 2 hours